Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol

Department of Psychiatry, Douglas Hospital Research Centre, McGill University, 6875 Boulevard LaSalle, Montreal, Québec, Canada H4H 1R3.
British Journal of Pharmacology (Impact Factor: 4.84). 04/2004; 141(6):997-1005. DOI: 10.1038/sj.bjp.0705688
Source: PubMed


Resveratrol, an active ingredient of red wine extracts, has been shown to exhibit neuroprotective effects in several experimental models.
The present study evaluated the neuroprotective effects of resveratrol against amyloid β(Aβ)-induced toxicity in cultured rat hippocampal cells and examined the role of the protein kinase C (PKC) pathway in this effect.
Pre-, co- and post-treatment with resveratrol significantly attenuated Aβ-induced cell death in a concentration-dependent manner, with a concentration of 25 μM being maximally effective.
Pretreatment (1 h) of hippocampal cells with phorbol-12-myristate-13-acetate, a PKC activator, at increasing concentrations (1–100 ng ml−1), resulted in a dose-dependent reduction in Aβ-induced toxicity, whereas the inactive 4α-phorbol had no effect.
Pretreatment (30 min) of hippocampal cells with GF 109203X (1 μM), a general PKC inhibitor, significantly attenuated the neuroprotective effect of resveratrol against Aβ-induced cell death.
Treatment of hippocampal cells with resveratrol (20 μM) also induced the phosphorylation of various isoforms of PKC leading to activation.
Taken together, the present results indicate that PKC is involved in the neuroprotective action of resveratrol against Aβ-induced toxicity.
British Journal of Pharmacology (2004) 141, 997–1005. doi:10.1038/sj.bjp.0705688

Download full-text


Available from: Wen Hua Zheng